The Beachbody Company, Inc. (BODi) 2025 Annual Report: Investor Key Highlights

Overview

The Beachbody Company, Inc. (“BODi”), headquartered in El Segundo, California, filed its 2025 Annual Report (Form 10-K) for the fiscal year ended December 31, 2025. This report contains several important disclosures that investors should be aware of, including operational performance, risks, capital structure, and regulatory compliance.

Key Points and Potentially Price-Sensitive Information

• Public Float and Share Structure: As of June 30, 2025, the aggregate market value of BODi’s voting and non-voting common equity held by non-affiliates was \$14,409,127. The Company has 4,450,721 shares of Class A Common Stock and 2,729,003 shares of Class X Common Stock outstanding as of March 3, 2026. These numbers are crucial for evaluating market capitalization and potential dilution risks.
• Listing and Trading Symbol: BODi’s Class A Common Stock trades on the Nasdaq Stock Market LLC under the symbol “BODI“. Investors should monitor trading activity for liquidity and volatility.
• Regulatory Compliance: The Company confirms it is not a shell company and has met all reporting obligations for the past 12 months. It is classified as a “Non-accelerated filer” and a “Smaller reporting company,” which means less regulatory scrutiny but potentially less analyst coverage.
• Forward-Looking Statements and Risks: The report includes a cautionary note regarding forward-looking statements, highlighting risks such as:
  • Uncertainties about future financial performance, including revenue, gross profit, operating expenses, and profitability.
  • Liquidity concerns and the ability to raise financing.
  • Compliance with financial covenants in the ABL Facility (Asset-Based Lending).
  • Warrants accounted for as liabilities—changes in their value could materially affect results.
  • Competitive risks in the fitness and nutrition industries.
  • Reliance on a few key products, which may expose the company to product-specific risks.
  • Exposure to market conditions and global economic factors.

  These risks could materially affect the share price if any become realized.

• Legal Proceedings & Governance: Legal proceedings, executive compensation, and related party transactions are disclosed in detail. Investors should review these for potential liabilities or governance concerns.
• Financial Reporting Controls: The Company has not filed a report on and attestation to management’s assessment of the effectiveness of internal controls over financial reporting under Section 404(b) of the Sarbanes-Oxley Act. This may indicate heightened risk of material weaknesses in financial controls, which could impact investor confidence.
• Proxy Statement Incorporation: Parts of the registrant’s definitive proxy statement for the 2026 Annual Meeting are incorporated by reference in Part III of the 10-K, including information on directors, executive officers, compensation, and stockholder matters.
• Segment Reporting & Key Definitions: The document provides definitions of key terms (ABL, OTT, RSU, CEO, CFO, SOFR, CPRA, ESG, GAAP, etc.), indicating the complexity of BODi’s business and the need for investors to be familiar with these concepts for proper analysis.

Potential Share Price Movers

• Liquidity and Financing: The company’s ability to comply with financial covenants and raise additional financing is highlighted as a key risk. Any news or developments regarding these issues could significantly impact share price.
• Warrant Liability Accounting: Changes in the value of warrants, especially those accounted for as liabilities, could have a material effect on financial results and share price volatility.
• Internal Controls: Lack of attestation to internal control effectiveness may raise concerns among institutional investors and could weigh on valuation.
• Product Concentration & Competition: Heavy reliance on a few key products and intense competition in the industry create risks that could affect revenue and profitability, impacting share price.

Investor Takeaways

• Monitor developments regarding liquidity, financing, and compliance with financial covenants.
• Watch for changes in warrant valuation and any new financial instruments that may affect results.
• Be aware of risks related to product concentration and competitive dynamics.
• Regulatory compliance and reporting status are currently positive, but the lack of attestation on internal controls warrants caution.

Disclaimer

This article summarizes publicly available information in The Beachbody Company, Inc.’s 2025 Annual Report on Form 10-K. It is intended for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult a financial advisor before making any investment decisions. The company’s forward-looking statements are subject to significant risks, uncertainties, and assumptions, and actual results may differ materially.

View Beachbody Company, Inc. Historical chart here